Monoclonal antibodies - PDFSEARCH.IO - Document Search Engine

Monoclonal antibodies
Results: 1533

#	Item
11	Press Release For Immediate Release June 5, 2016 Add to Reading List Source URL: www.ganymed-pharmaceuticals.com Language: English - Date: 2016-06-05 08:04:51 Clinical medicine Medicine Cancer RTT Monoclonal antibodies Antineoplastic drugs Cancer treatments IMAB362 Chemotherapy Ovarian cancer Lung cancer Treatment of cancer
12	Press release Clinical Phase I Results of GANYMED’s iMAB362 Antibody Demonstrate Excellent Safety Mainz, Germany, August 04, A clinical first-in-human Phase I multi center study with GANYMED’s monoclonal anti Add to Reading List Source URL: www.ganymed-pharmaceuticals.com Language: English - Date: 2015-02-04 05:15:07 Medicine Immunology Monoclonal antibodies Clinical medicine Biology Immune system Pathology Biotechnology IMAB362 Cancer Monoclonal antibody therapy Antibody
13	Press Release For Immediate Release October 21, 2013 Add to Reading List Source URL: www.ganymed-pharmaceuticals.com Language: English - Date: 2015-02-04 05:14:56 RTT Monoclonal antibodies IMAB362 Medicine Clinical medicine Treatment of cancer Cancer Health Pancreatic cancer Seattle Genetics
14	F-star announces funding and collaboration extension with new Christian Doppler Lab for Innovative Immunotherapeutics Strong academic bridge supports F-star’s leading, innovative position in immuno-oncology and bispeci Add to Reading List Source URL: www.f-star.com Language: English - Date: 2016-07-13 10:00:22 Medicine Clinical medicine Biology Biotechnology Immunology Monoclonal antibodies Immune system F-star Antibody Biopharmaceutical Bispecific monoclonal antibody Cancer immunotherapy
15	TABLE OF CONTENTS INTRODUCTION 2 Add to Reading List Source URL: www.abirisk.eu Language: English - Date: 2015-06-19 09:16:17 Medicine Immunology Clinical medicine Health care Immunosuppressants Biotechnology Monoclonal antibodies Immune system Immunogenicity Autoimmunity Infliximab Arthritis
16	24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO Box Add to Reading List Source URL: www.nzma.org.nz Language: English - Date: 2016-05-25 01:37:50 Clinical medicine Medicine Antineoplastic drugs Breakthrough therapy Pharmacology Bristol-Myers Squibb Monoclonal antibodies Immune system Programmed cell death protein 1 Nivolumab Pharmac Pembrolizumab
17	12 JulyGeraldine MacGibbon Senior Therapeutic Group Manager PHARMAC PO Box Add to Reading List Source URL: www.nzma.org.nz Language: English - Date: 2016-07-11 21:31:12 Clinical medicine Breakthrough therapy Medicine Antineoplastic drugs Pharmacology Monoclonal antibodies Bristol-Myers Squibb Nivolumab Melanoma Programmed cell death protein 1 Pembrolizumab Raltegravir
18	JUNE 2015 TABLE OF CONTENTS INTRODUCTION Add to Reading List Source URL: www.abirisk.eu Language: English - Date: 2015-10-20 13:17:42 Medicine Clinical medicine Health care Immunology Immunosuppressants Monoclonal antibodies Biotechnology Immune system Infliximab TNF inhibitor Rheumatology Biopharmaceutical
19	GANYMED lead antibodies show excellent efficacy and safety in mouse tumor models Mainz, Germany – April 5, 2006 – GANYMED Pharmaceuticals AG announced today that several monoclonal lead antibodies directed against th Add to Reading List Source URL: www.ganymed-pharmaceuticals.com Language: English - Date: 2015-02-04 05:14:57 Medicine Clinical medicine Health care Immunology Pathology Immune system Monoclonal antibodies Immunohistochemistry Antibody Cancer IMAB362 Racotumomab
20	Press release GANYMED closes EUR 65 M Financing Round November 18, 2008, Mainz - GANYMED Pharmaceuticals AG today announced the closing of a EUR 65 M financing round. The round was led by ATS Beteiligungsverwaltung GmbH Add to Reading List Source URL: www.ganymed-pharmaceuticals.com Language: English - Date: 2015-02-04 05:14:59 Medicine Monoclonal antibodies IMAB362 Clinical medicine Health Antibody Cancer Ganymed